Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1153/week)
    • Manufacturing(555/week)
    • Technology(1082/week)
    • Energy(396/week)
    • Other Manufacturing(315/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Cipher Pharmaceuticals Inc.

Feb 10, 2021
Cipher Pharmaceuticals Enters into Co-Promotion Agreement with Verity Pharmaceuticals Inc.
Jan 15, 2021
Cipher Pharmaceuticals Receives Arbitration Award on Trulance®
Oct 08, 2020
Cipher Pharmaceuticals Reports Voting Results for the Election of Directors
Aug 12, 2020
Cipher Pharmaceuticals Reports Second Quarter 2020 Financial Results
Jul 02, 2020
Cipher Pharmaceuticals Appoints New Chief Financial Officer
Apr 20, 2020
Cipher Pharmaceuticals Receives Positive Ruling on Binding Arbitration with Upsher-Smith Laboratories
Jan 20, 2020
Cipher Pharmaceuticals Receives Notice of Termination from Bausch
Nov 07, 2019
Cipher Pharmaceuticals Reports Third Quarter 2019 Financial Results
Oct 24, 2019
Notice of Cipher Pharmaceuticals Q3 2019 Conference Call
Jul 30, 2019
Notice of Cipher Pharmaceuticals Q2 2019 Conference Call
May 01, 2019
Notice of Cipher Pharmaceuticals Q1 2019 Conference Call
Mar 20, 2019
Cipher Pharmaceuticals Announces Change to Management Team
Mar 15, 2019
Notice of Cipher Pharmaceuticals Q4 2018 Conference Call
Dec 05, 2018
Cipher Pharmaceuticals to Host Investor Webcast on December 11TH, 2018
Nov 07, 2018
Cipher Pharmaceuticals Reports Q3 2018 Results
Oct 24, 2018
Cipher Pharmaceuticals Announces Canadian Launch of Brinavess® (vernakalant hydrochloride)
Sep 18, 2018
Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to MOB-015 from Moberg Pharma for the topical treatment of Onychomycosis
Aug 10, 2018
Cipher Pharmaceuticals Reports Q2 2018 Results
Jul 23, 2018
Notice of Cipher Pharmaceuticals Q2 2018 Conference Call
Jun 06, 2018
Cipher Pharmaceuticals Adds New Vice President, Scientific & Medical Affairs
  •  
  • Page 1
  • ››

Latest News

Jun 11, 2025

Voyager Announces Pricing of Initial Public Offering

Jun 11, 2025

H&P To Participate in J.P. Morgan 2025 Energy, Power and Renewables Conference

Jun 11, 2025

CACI President and CEO John Mengucci Named ‘Executive of the Year’ by ACG National Capital

Jun 11, 2025

Atlas Announces Timing of Second Quarter 2025 Earnings Release and Conference Call

Jun 11, 2025

Kaiser Aluminum Corporation Announces Appointment of Glenda J. Minor to its Board of Directors

Jun 11, 2025

The SEER Group Expands Northwest Presence With Acquisition of Oregon’s Associated Heating & Air...

Jun 11, 2025

Phillips 66 to Speak at the J.P. Morgan 2025 Energy, Power, Renewables & Mining Conference

Jun 11, 2025

Forum Energy Technologies to Present at the Sidoti Virtual Small Cap Conference

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia